The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing, Conversions, Warrants & Business Update

27 Jan 2021 07:00

RNS Number : 9835M
Catenae Innovation PLC
27 January 2021
 

27 January 2021

Catenae Innovation PLC

("Catenae", or the "Company")

 

Placing and Conversions, Issue of Warrants and Business Update

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that, conditional on admission to AIM, it has issued 52,400,000 new ordinary shares in relation to:

 

(1) the placing of 50,000,000 new ordinary shares raising £1,000,000 ("Placing" or "Placing Shares");

(2) the conversion of £13,000 of remuneration liabilities to certain directors into 650,000 new ordinary shares; and

(3) the settlement of other current liabilities of the Company amounting to £35,000 into 1,750,000 new ordinary shares (together with (2), the "Conversions" or "Conversion Shares").

 

The Placing and the Conversion have been issued at a price of 2.0 pence per share ("Issue Price").

 

The Placing, which was oversubscribed, has been conducted through Brandon Hill Capital Limited, the Company's broker. As part of its remuneration, Brandon Hill Capital Limited will receive a warrant over 750,000 new ordinary shares in the Company which may be exercised at a price of 3.0 pence per share at any time up to three years following the date of Placing Shares and the Conversion Shares being admitted to trading on AIM ("Broker Warrants").

 

Issue of Warrants

 

The holders of the Placing Shares and Conversion Shares will receive a warrant ("Warrant") to subscribe for a further 1 new ordinary share in the Company for each 2 Placing Shares or Conversion Shares held, which may be exercised at a price of 3.0 pence per share at any time up to two years following the date the Placing Shares and the Conversion Shares are admitted to trading on AIM.

 

In aggregate, warrants over 26,200,000 new ordinary shares compromising Warrants and Broker Warrants will be issued, conditional on admission of the Placing Shares and the Conversion Shares being admitted to trading on AIM.

 

Conversion

 

Details of the Conversion in relation to the directors are set out in the table below:

 

Director

Shareholding prior to Conversion

Liability subject to Conversion

Number of Conversion Shares issued

Number of shares granted under Warrant

Shareholding following Admission

Percentage shareholding following Admission

Guy Meyer

5,604,582

£10,000

500,000

250,000

6,104,582

2.23%

 

John Farthing

2,591,702

£3,000

150,000

75,000

2,741,702

1.00%

 

 

Use of proceeds

The net proceeds of the Placing will enable the Company to enhance its proprietary technology capabilities, build upon its business development strategy and for general working capital purposes.

 

Business Update

The Company's Covid-19 testing platform, in which it securely records and feeds results into Public Health England's database for use by the NHS' Test and Trace service, continues to be deployed by companies across a range of sectors, and has recently been implemented by:

 

· The pharmacy sector with 18 pharmacies;

· A festive season outdoor event (as announced on 15 December 2020);

· A major UK mobile operator; and

· Badminton England (as announced on 15 December 2020)

 

Catenae is pleased also to announce that, further to an extensive review of the Company's organisational and security processes, the Company was awarded ISO 27001 following an audit on behalf of the International Standards Organisation (ISO). The Company was also awarded a Cyber Essentials accreditation. The Cyber Essentials scheme is operated on behalf of the National Cyber Security Centre (NCSC).

 

Both accreditations are important to the Company given that they are a procurement requirement in many business and organisations.

 

Admission

Application will be made to the London Stock Exchange to admit 52,400,000 new ordinary shares to trading on AIM. Admission of the 52,400,000 new ordinary shares is expected to occur on or around 3 February 2021 ("Admission"). The new ordinary shares will rank pari passu with the existing ordinary shares.

 

Total Voting Rights

For the purpose of the Disclosure and Transparency Rules, following the issue of shares detailed above, the enlarged issued share capital of the Company will comprise 273,491,508 ordinary shares of 0.2 pence each.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

 

Guy Meyer, Chief Executive Officer, Catenae, said: "We are pleased to have been able to raise capital, which will allow us to accelerate the execution of our growth strategy both through our joint venture, Synovate Global Limited, and independently as Catenae.

 

"The ISO 27001 and Cyber Essentials accreditations demonstrate the Company's commitment to ensuring data protection and GDPR compliance in today's world where customers place increasing importance on being able to trust their service providers. These accreditations sit well within our blockchain ecosystem and further differentiate us from our competitors.

 

"The Company has a growing pipeline of opportunities ahead and looks forward to updating the market further in due course."

-Ends-

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company and the Directors of the Company accept responsibility for the content of this announcement.

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins / Matthew McHale

 

Notes to Editors:

 

About Catenae Innovation PLC

 

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

 

www.catenaeinnovation.com

 

About Synovate Global Ltd

Synovate Global delivers cutting edge medical products supported by clinical and occupational health services underpinned by undisputed blockchain technology to enable you to mitigate risk and proactively manage your populations' health status.

 

https://www.synovateglobal.com

 

About ISO 27001

 

ISO/IEC 27001:2013 specifies the requirements for establishing, implementing, maintaining and continually improving an information security management system within the context of the organisation. It also includes requirements for the assessment and treatment of information security risks tailored to the needs of the organisation.

 

https://www.iso.org/isoiec-27001-information-security.html

About The National Cyber Security Centre

Launched in October 2016, the NCSC has headquarters in London and brings together expertise from CESG (the information assurance arm of GCHQ), the Centre for Cyber Assessment, CERT-UK, and the Centre for Protection of National Infrastructure.

The NCSC provides a single point of contact for SMEs, larger organisations, government agencies, the general public and departments. They also work collaboratively with other law enforcement, defence, the UK's intelligence and security agencies and international partners.

 

https://www.ncsc.gov.uk

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

a) Guy Meyer

b) John Farthing

2

Reason for notification

a.

Position/Status

a) CEO

b) CFO

b.

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Catenae Innovation plc

 

b.

LEI

2138007I2D8YWPMSP544

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 0.2 pence each

 

ISIN: GB00BKM6CG53

 

b.

Nature of the transaction

 Issue of shares

c.

Price(s) and volume(s)

Price(s) per share

Volume(s)

a) 2p

b) 2p

a) 500,000

b) 150,000

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

650,000

 

2p

e.

Date of the transaction

27 January 2021

f.

Place of the transaction

AIM, London Stock Exchange

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

a) Guy Meyer

b) John Farthing

2

Reason for notification

a.

Position/Status

a) CEO

b) CFO

b.

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Catenae Innovation plc

 

b.

LEI

2138007I2D8YWPMSP544

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Warrants over ordinary shares of 0.2 pence each

 

ISIN: GB00BKM6CG53

 

b.

Nature of the transaction

 Grant of warrants

c.

Price(s) and volume(s)

Price(s) per share

Volume(s)

a) 3p

b) 3p

a) 250,000

b) 75,000

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

325,000

3p

e.

Date of the transaction

27 January 2021

f.

Place of the transaction

AIM, London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDDGDBXGDDGBL
Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.